On Tuesday, Editas Medicine Inc (NASDAQ: EDIT) opened lower -6.01% from the last session, before settling in for the closing price of $2.33. Price fluctuations for EDIT have ranged from $0.91 to $4.54 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -1.48% over the last five years. Company’s average yearly earnings per share was noted 31.20% at the time writing. With a float of $97.12 million, this company’s outstanding shares have now reached $97.62 million.
The firm has a total of 246 workers. Let’s measure their productivity.
Editas Medicine Inc (EDIT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Editas Medicine Inc is 0.51%, while institutional ownership is 45.44%. The most recent insider transaction that took place on Dec 03 ’25, was worth 1,535. In this transaction EVP, CHIEF SCIENTIFIC OFFICER of this company sold 713 shares at a rate of $2.15, taking the stock ownership to the 68,777 shares. Before that another transaction happened on Dec 03 ’25, when Company’s CEO sold 5,603 for $2.15, making the entire transaction worth $12,064. This insider now owns 269,087 shares in total.
Editas Medicine Inc (EDIT) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.55 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.33) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.82% during the next five years compared to -1.48% drop over the previous five years of trading.
Editas Medicine Inc (NASDAQ: EDIT) Trading Performance Indicators
Check out the current performance indicators for Editas Medicine Inc (EDIT). In the past quarter, the stock posted a quick ratio of 2.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.38, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.09 in one year’s time.
Technical Analysis of Editas Medicine Inc (EDIT)
Analysing the last 5-days average volume posted by the [Editas Medicine Inc, EDIT], we can find that recorded value of 2.11 million was lower than the volume posted last year of 2.68 million. As of the previous 9 days, the stock’s Stochastic %D was 6.73%.
During the past 100 days, Editas Medicine Inc’s (EDIT) raw stochastic average was set at 4.86%, which indicates a significant decrease from 12.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.17 in the past 14 days, which was lower than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.79, while its 200-day Moving Average is $2.37. Now, the first resistance to watch is $2.31. This is followed by the second major resistance level at $2.42. The third major resistance level sits at $2.52. If the price goes on to break the first support level at $2.10, it is likely to go to the next support level at $2.00. Now, if the price goes above the second support level, the third support stands at $1.89.
Editas Medicine Inc (NASDAQ: EDIT) Key Stats
There are currently 97,619K shares outstanding in the company with a market cap of 213.78 million. Presently, the company’s annual sales total 32,310 K according to its annual income of -237,090 K. Last quarter, the company’s sales amounted to 7,540 K and its income totaled -25,120 K.
